Bioengineered Proteins and Enzymes Market is expected to reach USD 11.5 billion by 2031

Bioengineered proteins and enzymes market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the bioengineered proteins and enzymes market will expand from USD 6.9 billion in 2026 to USD 11.5 billion in 2031 at a CAGR of 10.8% during the forecast period.

Rapid changes are being observed in the market with engineered proteins and enzymes being used in therapeutic, industrial biotechnology, food processing, biofuels and agricultural applications etc. With the advances in genetic engineering, directed evolution and fermentation technologies, manufacturers now have the capability to create more stable, more specific, and more productive proteins and enzymes. Also, the focus on sustainable manufacturing processing and eco-friendly industrial processes is driving the rising trend of using bioengineered enzymes over chemical catalysts.Furthermore, the rise in the popularity of bioengineered enzymes for replacing chemical catalysts is due to sustainable manufacturing process and eco-friendly industrial process.

Request a free sample copy or view the report summary: Bioengineered proteins and enzymes market Report

Bioengineered proteins and enzymes market Report Highlights

• By Product Type, therapeutic proteins are the major segment in the market as the rising use of therapeutic proteins in chronic diseases like diabetes, cancer, autoimmune disorders, and so on. The food processing and detergent and textiles industry, along with biofuels, are the key application areas for the industrial enzymes market, given their efficient and eco-friendly nature. Recombinant proteins, specialty proteins are also gaining momentum to be used in various research, diagnostic and personalized medicine applications and biosimilars are steadily rising as cost effective alternatives to the branded biologics.

• By application, the biopharmaceuticals will constitute the largest share of the market due to the growing production of biologics and the increasing use of protein-based therapeutics. Investments in biotechnology and molecular diagnostics are steadily increasing, and diagnostics & research applications are also expanding. Food & beverages and animal feed & nutrition are experiencing significant growth with the use of enzymes for enhancing the quality of products, digestibility and processing efficiency. Moreover, in biofuels & energy, detergents & textiles, agriculture & crop protection, cosmetics & personal care, and environmental biotechnology sectors, demand is rising with a focus on sustainable and bio-based solutions.

• By End-user, Pharmaceutical & biotechnology companies are dominating the market with the growing investment in development and large scale production of biologics. Contract research and manufacturing organizations (CROs/CDMOs) are growing fast: with the increasing outsourcing of the protein and enzyme development and manufacturing processes, it is expected that companies will benefit from cost and flex reduction. Academic and research institutions are still playing a significant role by innovation and early research activities, and industrial manufacturers, food & beverage manufacturers, agriculture & livestock companies are increasingly turning to engineered enzymes and proteins to increase efficiency, productivity and sustainability.

• Geographically, North America is the largest market for the biotechnology industry, as it has the most developed biotechnology infrastructure, high levels of research and development spending, and a large population of established biopharmaceutical companies. Demand for sustainable industrial enzymes is driving significant growth in Europe, while regulatory support for biotechnology innovation is also bolstering growth. Moreover, Asia-Pacific is projected to exhibit the fastest growth rate as the countries such as China, India, and Japan are witnessing a significant rise in research activities, pharmaceutical manufacturing, and healthcare investments. South America and MEA are gradually gaining in size in awareness of biotechnology applications and enhancements of industrial capabilities.

Bioengineered proteins and enzymes market Growth Drivers and Restraints

Growth Drivers:

• Increasing Demand for Biologics and Therapeutic Proteins: The rising prevalence of chronic diseases and the need for targeted therapies are driving a surge in the use of recombinant proteins and enzyme-based therapeutics.

• Advancements in Protein Engineering and Synthetic Biology: Technological developments in Protein Engineering and Synthetic Biology are enabling the production of highly efficient and customized enzymes and proteins for pharmaceutical, industrial and environmental applications.

Restraints:

• High Production Costs and Complex Manufacturing Processes: The production and commercialisation of bioengineered proteins and enzymes involve complex technologies, specialised manufacturing set-ups and high investment requirements.

• Regulatory and Stability Challenges: Market growth can be affected by strict regulatory requirements concerning product safety, efficacy and quality, as well as by stability and storage issues for biologics.

Bioengineered proteins and enzymes market Key Development

• Product Launch: In May 2026, Caravel Bio, the company engineering industrial-strength proteins from discovery to deployment, announced its participation in the Shell GameChanger program, where it is receiving funding to assess the potential of its unique biocatalyst development technology to enable lower-cost, more efficient carbon capture.

Bioengineered proteins and enzymes market Segmentation

Knowledge Sourcing Intelligence has segmented the bioengineered proteins and enzymes by product type, application, end-user, and geography:

Bioengineered proteins and enzymes market, By Product Type

• Recombinant Proteins

• Therapeutic Proteins

• Industrial Enzymes

• Diagnostic Enzymes

• Specialty Proteins

• Biosimilars

Bioengineered proteins and enzymes market, By Application

• Biopharmaceuticals

• Diagnostics & Research

• Food & Beverages

• Animal Feed & Nutrition

• Biofuels & Energy

• Detergents & Textiles

• Agriculture & Crop Protection

• Cosmetics & Personal Care

• Environmental Biotechnology

Bioengineered proteins and enzymes market, By End-User

• Pharmaceutical & Biotechnology Companies

• Contract Research and Manufacturing Organizations (CROs/CDMOs)

• Academic and Research Institutions

• Industrial Manufacturers

• Food & Beverage Manufacturers

• Agriculture & Livestock Firms

Bioengineered proteins and enzymes market, By Region

• North America

  • USA

  • Canada

  • Mexico

• South America

  • Brazil

  • Argentina

  • Others

• Europe

  • United Kingdom

  • Germany

  • France

  • Spain

  • Others

• Middle East and Africa

  • Saudi Arabia

  • UAE

  • Others

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Thailand

  • Others

Bioengineered Proteins and Enzymes Market Key Players

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Bio-Techne Corporation

• Abcam plc

• GenScript Biotech Corporation

• Sino Biological Inc.

• Novonesis

• Codexis, Inc.

• BASF SE

• Advanced Enzyme Technologies Ltd.